Katharina Filarsky

Company: Bayer AG

Job title: Head of Assays 3 in Biologics Research

Seminars:

Determining the Anti-Tumoral Activity of BAY 3375968: An Afucosylated Anti-CCR8 Antibody Which Depletes Activated Intratumoral Tregs via the Innate Immune System to Kill Cancer 1:30 pm

Understanding Treg promotion of cancer by suppressing the function of CD8+ and CD4+ T cells in the TME to hamper the efficacy of immune checkpoint inhibitors Harnessing BAY 3375968 by simultaneous binding to CCR8 on Tregs and to Fcγ receptors on effector cells to induce ADCC and ADCP to mediate the cancer kills Utilising assays…Read more

day: Day One